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1. Background & Objectives
Notwithstanding refinement of preoperative
staging, a number of procedures still end in an
exploratory thoracotomy (E.T), due to unexpected
findings.
The aim of this work is to evaluate the validity of
routine videothoracoscopy - performed as the
first step of the planned resection for NSCLC - to
assess tumor resectability and feasibility of the
resection through thoracoscopy.
2. Patients & Methods
From November 1991 to December 2007, 1306
patients with NSCLC, candidates for curative
surgery after conventional staging, underwent
routine VATS exploration immediately before the
planned operation.
Preoperative staging included Chest X-rays, CT
scan of the thorax, upper abdomen, brain, and
bronchoscopy. Mediastinoscopy was carried out
in cases of suspected N3 disease or extracapsular
N2 invasion.
When thoracoscopy demonstrated clear
unresectability the procedure was concluded. In
any case of doubt, it was converted to
thoracotomy. When feasible and indicated,
thoracoscopic resection was performed.
The clinical charts have been retrospectively
reviewed, and data analyzed by SPSS 16.0
software.
3. Results
Morbidity and mortality
specifically related to
thoracoscopy has been
absent.
Thoracoscopy, resulted
highly reliable in exclu-
ding causes of unresec-
tability, (NPV 0.97 ).
The global accuracy rate
was 73.3%. (graph C)
The difference in the
rate of correctly staged
patients by CT and by
thoracoscopy was signi-
ficant. (p<0.001).
E.T. rate after the
adoption of preliminary
VATS decreased to 2.4%.
4. Comments
In our previous series from 1980 to 1991 the E.T.
rate had been 11.6%. In the present series, after
the introduction of routine thoracoscopy, as the
unique major variation of the staging protocol,
the E.T. rate is 2.4%.
Considering the 58 pts in whom thoracoscopy
revealed an unexpected cause of inoperability and
the 449 pts in whom it confirmed the feasibility
of a VATS resection, thoracoscopy spared an
unnecessary thoracotomy in 507 (38.8%) patients.
Technical and anatomical problems can limit the
accuracy of preliminary VATS
5. Conclusions
Routine videothoracoscopy immediately before 
the planned operation for lung cancer:
• provides  precise assessment of tumor extension 
and resectability;
• allows the surgeon to decide for a thoracoscopic
or an open resection, and
•minimizes the number of unnecessary 
thoracotomies. 
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LEGEND: Using  as the benchmark the final  pTNM staging of pts submitted 
to VATS, the rates of cases (Figs. A  and C) and the number of cases (Figs. B 
and D) understaged, correctly staged, or overstaged by CT or  VATS are 
reported.
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